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Introduction: Disease progression of ankylosing spondylitis has been considered irreversible. However, we report a
case of spontaneous regression of syndesmophyte development following allogeneic peripheral blood stem cell
transplantation in a patient with acute myeloid leukemia, who was also diagnosed as having ankylosing spondylitis.
To the best of our knowledge, this is the first case report presenting the partial radiologic regression of
syndesmophytes.
Case presentation: A 39-year-old man with active ankylosing spondylitis achieved clinical remission and partial
radiological regression of cervical spine syndesmophytes following a peripheral blood stem cell transplantation for
acute myeloid leukemia. Our patient received an allogeneic peripheral blood stem cell transplantation following a
pre-transplantation conditioning regimen of total body irradiation and cyclophosphamide. The donor was a human
leukocyte antigen-matched 29-year-old man. Our patient has remained asymptomatic and has received no
medication for ankylosing spondylitis for nearly three years.
Conclusions: Several explanations are proposed for the regression of syndesmophytes and clinical improvement in
active ankylosing spondylitis observed in our patient, including changes in bone remodeling and immune
reconstitution following stem cell transplantation, the effect of immunosuppressive agents, or fluctuation in the
natural course of ankylosing spondylitis although further studies are required. The regression of syndesmophytes in
ankylosing spondylitis in this case raises the possibility that stem cell transplantation might contribute to the
development of a novel therapeutic strategy for treatment of the disease.Introduction
Ankylosing spondylitis, an inflammatory rheumatologic
disease that affects the axial skeleton resulting in charac-
teristic inflammatory back pain, is uniquely associated
with the major histocompatibility complex class I mol-
ecule, human leukocyte antigen (HLA)-B27 [1]. The
current goals for treatment of this disease involve efforts
to improve quality of life through pain control and allevi-
ation of inflammation, prevent progressive structural
damage, and preserve motor function [2]. Therapeutic
modalities include non-pharmacological treatment such* Correspondence: juji@catholic.ac.kr
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reproduction in any medium, provided the oras regular exercise, and pharmacological treatment in-
cluding non-steroidal anti-inflammatory drugs (NSAIDs),
analgesics, glucocorticoids, disease-modifying anti-
rheumatic drugs, and anti-tumor necrosis factor (TNF)
therapy. Surgical treatment may be considered for se-
verely disabling deformities. One of the hallmarks of
ankylosing spondylitis is the formation of vertebral syn-
desmophytes, which may lead to diminished physical
function and restricted spinal motion [3]. Disease pro-
gression and structural damage have been considered
irreversible; however, we report a case of spontaneous
regression of syndesmophyte development following
allogeneic peripheral blood stem cell transplantation in
a patient with acute myeloid leukemia, who was also
diagnosed as having ankylosing spondylitis.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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A 39-year-old man was admitted to the hematologic de-
partment of our facility for peripheral blood stem cell
transplantation in April 2009, following an initial diag-
nosis of acute myeloid leukemia in October 2008. An
initial complete remission was achieved with induction
chemotherapy and two cycles of consolidation chemo-
therapy with an IDV/BHAC (idarubicin-N4-behenoyl-L-
β-D arabinofuranosyl-cytosine) regimen. Prior to the
stem cell transplantation, our patient was referred to a
rheumatologist for consultation regarding progressive
neck pain and stiffness. He had been diagnosed as hav-
ing ankylosing spondylitis 20 years previously, but never
received regular clinical treatment or follow-up. Add-
itionally, he was also not receiving regular medication
for ankylosing spondylitis, but was instead using painkil-
lers such as nonsteroidal anti-inflammatory drugs
(NSAIDs) or intermittent physical rehabilitation to alle-
viate the progressively worsening neck pain. A physical
examination of our patient revealed limited motion of
the cervical spine, although his chest expansion and the
range of motion of the lumbar spine were within normal
limits. The peripheral blood counts reported were as fol-
lows: hemoglobin, 10.6g/dL; white blood cell count,
4720 × 109 cells/L with normal differential cell count;
and platelets, 128 × 109 cells/L. His erythrocyte sedimen-
tation rate was 66mm/hour and his C-reactive protein
level was 0.29mg/dL. The results of immunological stud-
ies were negative for anti-nuclear antibody and both
complement and immunoglobulin levels were within
normal ranges, although HLA-B27 was positive. Urine
analysis results were unremarkable. Radiologic findings
were consistent with ankylosing spondylitis: bilateral
sacroiliac joint fusion and bamboo spine. Examination ofFigure 1 Cervical spine X-rays. Serial X-rays of the cervical spine revealed
regression following peripheral blood stem cell transplantation in April 200the cervical spine revealed C5 to C6 disc space narrow-
ing with the formation of syndesmophytes.
Our patient was initially treated with NSAIDs and was
scheduled to receive anti-TNF therapy following stem
cell transplantation. In April 2009, he received allogeneic
peripheral blood stem cell transplantation following a
pre-transplantation conditioning regimen of 1320cGy
total body irradiation and 60mg/kg cyclophosphamide
for two days. The donor was an HLA-matched 29-year-
old man. The HLA phenotype of our patient was A
1102, 3303; B 2704, 5801; C 0302, 1202 and that of the
donor was the same. Our patient received an intraven-
ous injection of 0.03mg/kg tacrolimus following oral ad-
ministration of 0.120mg/kg tacrolimus, and intravenous
injection of 5mg/body surface area methotrexate for
graft-versus-host disease (GVHD) prophylaxis. No evi-
dence of acute GVHD was reported following stem cell
transplantation. Our patient was discharged one month
following the stem cell transplantation without any
complications.
Five months after the peripheral blood stem cell trans-
plantation, our patient reported reduced posterior neck
pain, and an X-ray of the cervical spine revealed partial
regression of the syndesmophytes (Figure 1). A magnetic
resonance imaging (MRI) scan of our patient’s spine
25 months after the peripheral blood stem cell trans-
plantation indicated no osteitis in the cervical spine
(Figure 2). Furthermore, neither anti-TNF therapy or
NSAID medication were prescribed due to our patient’s
improved condition. Our patient has remained asymp-
tomatic and has received no medication for ankylosing
spondylitis for nearly three years. He received immuno-
suppressive therapy with tacrolimus for seven months
following the peripheral blood stem cell transplantation,syndesmophyte formation between C5 and C6 and subsequent
8.
Figure 2 Magnetic resonance imaging scan of the spine from
May 2011. The magnetic resonance imaging scan acquired in May
2011 indicated no evidence of osteitis in the cervical spine.
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condition has been stable without any recurrence of the
hematologic disease.Discussion
To the best of our knowledge, this is the first case report
presenting partial radiologic regression of syndesmo-
phytes in a patient with ankylosing spondylitis. In our
patient’s case, an individual positive for HLA-B2704
received a peripheral blood stem cell transplantation
from an unrelated fully matched donor who was also
positive for HLA-B2704. It is not clear whether and how
the immunological change following the peripheral
blood stem cell transplantation induced spontaneous re-
gression of the syndesmophytes.
Several previous studies have reported feasible associa-
tions between hematologic malignancies, stem cell trans-
plantation, and rheumatologic disease. Jantunen et al.
reported complete clinical remission in active ankylosing
spondylitis following chemotherapy and autologous stem
cell transplantation for lymphoma [4]. However, the de-
velopment of rheumatologic manifestations, such as
arthralgias and arthritis, have been reported following
allogeneic bone marrow transplantation or peripheral
blood stem cell transplantation [5]. Some cases of
hematological malignancies were preferentially expressed
in HLA-B27 carriers [6]. Hematopoietic stem cell trans-
plantation and resetting the immune system for severe
autoimmune disease have proven to be effective forms
of treatment in some cases [7].Several explanations are proposed for the regression of
syndesmophytes and clinical improvement in active an-
kylosing spondylitis observed in our patient, including
changes in bone remodeling and immune reconstitution
following stem cell transplantation, the effect of im-
munosuppressive agents, or fluctuation in the natural
course of ankylosing spondylitis although further studies
are required. Comparison of MRI scan results acquired
before and after peripheral blood stem cell transplant-
ation would provide more information about changes in
bony structure, but pre-transplant images were not avail-
able for our patient. The partial regression of syndesmo-
phytes in ankylosing spondylitis in this case raises the
possibility that stem cell transplantation might contrib-
ute to the development of a novel therapeutic strategy
for treatment of the disease.
Conclusions
We report a case of partial radiologic regression of syn-
desmophytes in a patient with ankylosing spondylitis.
Our case raises the possibility that stem cell transplant-
ation may contribute to the development of a novel
therapeutic strategy for this disease.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for re-
view by the Editor-in-Chief of this journal.
Competing interests
The authors declare that they have no competing interests. This research
was partially supported by Basic Science Research Program through the
National Research Foundation of Korea (NRF) funded by the Ministry of
Education, Science and Technology (331-2008-1-E00144).
Authors’ contributions
HKY and SJM were the main authors and performed the clinical assessment
and follow-up. JHS and SKK performed the clinical assessment and
bibliographic research. KSP, SHP and HYK were major contributors in the
writing the manuscript. JHJ performed the clinical assessment and
bibliographic research as a corresponding author. All authors have read and
approved the final manuscript.
Author details
1Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary’s
Hospital, College of Medicine, Catholic Institute of Medical Science, The
Catholic University of Korea, 505 Banpo-dong, Seocho-gu, Seoul, South
Korea. 2Division of Rheumatology, Department of Internal Medicine, Seoul St.
Mary’s Hospital, College of Medicine, Catholic Institute of Medical Science,
The Catholic University of Korea, Wonmi-gu, Bucheon, Gyeonggi-do, South
Korea.
Received: 13 February 2012 Accepted: 8 June 2012
Published: 21 August 2012
References
1. Braun J, Sieper J: Ankylosing spondylitis. Lancet 2007, 369:1379–1390.
2. Braun J, van den Berg R, Baraliakos X, Boehm H, Burgos-Vargas R, Collantes-
Estevez E, Dagfinrud H, Dijkmans B, Dougados M, Emery P, Geher P,
Hammoudeh M, Inman RD, Jongkees M, Khan MA, Kiltz U, Kvien T, Leirisalo-
Repo M, Maksymowych WP, Olivieri I, Pavelka K, Sieper J, Stanislawska-
Yang et al. Journal of Medical Case Reports 2012, 6:250 Page 4 of 4
http://www.jmedicalcasereports.com/content/6/1/250Biernat E, Wendling D, Ozgocmen S, van Drogen C, van Royen B, van der
Heijde D: 2010 update of the ASAS/EULAR recommendations for the
management of ankylosing spondylitis. Ann Rheum Dis 2011, 70:896–904.
3. Landewé R, Dougados M, Mielants H, van der Tempel H, van der Heijde D:
Physical function in ankylosing spondylitis is independently determined
by both disease activity and radiographic damage of the spine. Ann
Rheum Dis 2009, 68:863–867.
4. Jantunen E, Myllykangas-Luosujarvi R, Kaipiainen-Seppanen O, Nousiainen T:
Autologous stem cell transplantation in a lymphoma patient with a long
history of ankylosing spondylitis. Rheumatology (Oxford) 2000, 39:563–564.
5. Koch B, Kranzhofer N, Pfreundschu M, Pees HW, Trumper L: First
manifestations of seronegative spondylarthropathy following autologous
stem cell transplantation in HLA-B27-positive patients. Bone Marrow
Transplant 2000, 26:673–675.
6. Au WY, Hawkins BR, Cheng N, Lie AK, Liang R, Kwong YL: Risk of
haematological malignancies in HLA-B27 carriers. Br J Haematol 2001,
115:320–322.
7. Tyndall A, Gratwohl A: Adult stem cell transplantation in autoimmune
disease. Curr Opin Hematol 2009, 16:285–291.
doi:10.1186/1752-1947-6-250
Cite this article as: Yang et al.: Regression of syndesmophyte after bone
marrow transplantation for acute myeloid leukemia in a patient with
ankylosing spondylitis: a case report. Journal of Medical Case Reports 2012
6:250.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
